In the United States called the scale of expenditures on advertising of medicines

In the United States called the scale of expenditures on advertising of medicines

KIEV. April 1. UNN. Spending by U.S. pharmaceutical companies on advertising of medicines record grow. This is evidenced by the results of a recent study conducted by experts at Dartmouth College (USA), reports UNN with reference to qz.com.

It is reported that in 1997, U.S. pharmaceutical companies spent on advertising prescription drugs 17.1 billion dollars, in 2016 this figure reached 26.9 billion. Almost 75% of spending (20.3 billion USD). went to the promotion of drugs by pharmaceutical companies to doctors.

“Marketing for doctors involves sending paid representatives to doctors’ offices to discuss the product, provide free samples and raise the question of possible compensation for the promotion of medicines by a doctor,” – said in the message.

It is also reported that between 1999 and 2016, the expenditure of the US population on prescription drugs increased from 116,4 to 329 billion dollars.

Recall, for hidden advertising is the “right” drugs the pharmacy network take almost 200 million UAH monthly.

Also recall that the Ukrainian policy submitted to the Parliament a bill on the reform of the pharmacy market (No. 8591-d). There the authors suggested to restrict the number of pharmacies from one owner to 4 institutions or to 15, if the pharmacy will have licensed the manufacture of drugs within the same region.

Categorically against this initiative were made by the representatives of large chain pharmacy business. For fear of losing its monopoly position on the market, they are actively discredited rules of the proposed “pharmacy law” in the media, says Elena Prudnikova.

The expert notes that small and medium-sized pharmacy business fully support the proposed Parliament, “pharmacy” bill, because its provisions can stop the discrimination of small pharmacies in the market.